Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prevention in cardiovascular pathology].

B Chamontin1, J Amar

  • 1Service de Médecine Interne et d'Hypertension Artérielle, Pavillon Turiaf, Place du Docteur Baylac, 31059 Toulouse, France.

Therapie
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Corneal perforations in patients on tyrosine kinase inhibitors].

Journal francais d'ophtalmologie·2023
Same author

Essential competencies in prescribing: A first european cross-sectional study among 895 final-year medical students.

Clinical pharmacology and therapeutics·2016
Same author

Causes of secondary hypertension in the young population: A monocentric study.

Annales de cardiologie et d'angeiologie·2016
Same author

[Medication reconciliation at hospital discharge focusing on patient with hypertension: Analysis of the output prescription].

Annales de cardiologie et d'angeiologie·2016
Same author

Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology.

Journal of human hypertension·2016
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015

Evaluating cardiovascular risk is key for managing hypertension and hypercholesterolemia. Treatment decisions, especially for primary prevention in high-risk individuals, should align with national guidelines and patient education is vital.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Context:

  • Cardiovascular risk assessment is crucial for managing arterial hypertension and hypercholesterolemia.
  • Existing risk equations like Anderson's (Framingham) may not be suitable for all populations, necessitating localized risk estimation.
  • Recommendations emphasize treatment decisions based on absolute cardiovascular risk, particularly for primary prevention.

Purpose:

  • To highlight the importance of evaluating absolute cardiovascular risk in clinical practice for managing hypertension and hypercholesterolemia.
  • To discuss the limitations of generic risk assessment tools and the need for population-specific models.
  • To underscore the benefits of pharmacological interventions for hypertension and hypercholesterolemia, especially in high-risk individuals.

Summary:

Related Experiment Videos

  • National and international guidelines advocate for cardiovascular risk assessment to guide treatment decisions for hypertension and hypercholesterolemia.
  • While Anderson's equation is proposed, its applicability is limited, stressing the need for country-specific risk evaluations.
  • The benefits of treating hypertension (beta-blockers, diuretics, ACE inhibitors, calcium antagonists) and hypercholesterolemia (statins) are well-established, with greater benefits observed at higher cardiovascular risk levels.
  • Secondary prevention is effective, but the focus here is primary prevention, particularly for high-risk patients from an economic perspective.
  • Informing the general population about cardiovascular risk factors and promoting patient education through healthcare networks are essential.

Impact:

  • Emphasizes the need for tailored cardiovascular risk assessment tools for effective disease management.
  • Reinforces the established benefits of pharmacological interventions in reducing cardiovascular events.
  • Promotes a public health approach focused on patient education and awareness of cardiovascular risk factors.